CD BioSciences is a cutting-edge biotechnology company committed to providing 3D bioprinted tissue and organ micro-models. With a team of experienced experts and a unique 3D printing technology platform called 3Dmicroflu™, we can provide you with relevant research services covering various life science fields. One of the very important applications of 3Dmicroflu™ technology platform for printing tissue and organ micro-models is drug development, for which drug action mechanism studies are a very important part.
Drug action is the reaction produced by the interaction between drugs and the organism. When drugs come into contact with or enter the body, they promote changes in the physiological and biochemical functions of the body's surface and internal environment, or inhibit invading pathogens and help the body improve its ability to resist disease, so as to achieve the effect of preventing and controlling diseases.
In pharmacological studies, the action of the organism on the drug is generally referred to as pharmacokinetics, while the action of the drug on the organism is generally referred to as pharmacodynamics. These two aspects are the basis of drug action studies. Here, CD BioSciences can help you with your pharmacology research through 3D bioprinting.
Pharmacokinetics (PK) and pharmacodynamics (PD) are two closely related kinetic processes that proceed in parallel by time. The former focuses on elucidating the action of the drug on the body, and is the kinetic process of absorption, distribution, metabolism and excretion of the drug in the body and its elimination. The latter describes the action of the drug on the body, the kinetic process by which the drug effect varies with time and concentration. CD BioSciences focuses on providing micro-models that truly reflect the physiological characteristics of the drug mechanism of action process through 3Dmicroflu™ high-resolution technology platform.
Pharmacokinetic studies are an important part of pharmacology and an important step in the drug development process. 3Dmicroflu™ technology platform provides a wide range of in vitro organ models for pharmacokinetic studies, which truly reflect the in vivo physiological environment and characteristics. The high-resolution 3Dmicroflu™ technology platform based on single-cell print culture allows you to print highly accurate and detailed pharmacokinetic models, helping you to obtain various data on drug concentration profiles over time after drug administration.
Pharmacokinetic studies are an important part of the drug development process and are essential for formulating dosing regimens, determining doses, guiding rational drug use and improving drug dosage forms. Here, our experienced team of experts from CD BioSciences can provide you with in vitro microtissue and organ models for pharmacokinetic studies based on the high-resolution 3Dmicroflu™ technology platform. 3Dmicroflu™ technology platform for pharmacokinetic studies is mainly used for drug safety evaluation including drug toxicity studies and drug tolerability analysis.
Pharmacokinetic and pharmacodynamic studies are fundamental to the drug development process that play an important role in assessing drug application potential and drug screening. Our high-resolution and high-throughput 3Dmicroflu™ technology platform can greatly facilitate the drug discovery process.
If you are interested in 3Dmicroflu™ technology platform involved in drug action mechanism research during drug development, please feel free to contact us for customization services. We always hope that our technology platform will be of great help and provide guidance to your R&D process. All services from CD BioSciences are available on a 24/7/365 basis.